Rosemary

Salvia rosmarinus (synonym Rosmarinus officinalis) is an evergreen shrub native to the Mediterranean basin—coasts and hills of Iberia, the Maghreb, Italy, the Balkans, and adjacent islands—and now planted worldwide in dry gardens. It prefers full sun, sharp drainage, and a winter that does not stay wet. Stems become woody; young growth is square in cross-section, as in other Lamiaceae. Leaves are opposite, linear, needle-like, dark green above and paler beneath, with rolled margins and dense glandular hairs that hold the camphoraceous-cineole scent. Flowers are two-lipped, typically pale blue to lilac (sometimes pink or white), with two long-exserted stamens—one of the morphological rhymes that helped phylogenists fold Rosmarinus into Salvia.

The 2017 recircumscription in Taxon (Drew and colleagues) placed rosemary inside a broadly defined Salvia because the old genus Rosmarinus sat nested among sages. Kew’s Plants of the World Online accepts Salvia rosmarinus Spenn. Labels did not all follow. If a bottle says R. officinalis, it is still this plant unless the seller has mixed in another salvia. It is not garden sage (Salvia officinalis), not white sage (S. apiana), and not “rosemary” as a perfume accord without the leaf.

Chemotypes matter for the oil. Distillations are often grouped by dominant volatiles: 1,8-cineole (eucalyptol), camphor, or verbenone/borneol patterns, plus α-pinene. Spanish, Moroccan, and Tunisian commercial oils are not interchangeable drop for drop. The dried leaf (Rosmarini folium) is a different pharmacognostic object from the essential oil (Rosmarini aetheroleum). Leaf also carries phenolic diterpenes—carnosic acid and carnosol—and the caffeic ester rosmarinic acid, which food chemists prize as antioxidants. Those phenolics are why rosemary extract, not the perfume oil, became an EU food additive.

The part used in the kitchen and in most traditional teas is the leaf, fresh or dried. Flowering tops go into some distillations. Do not assume a hedge clipping matches a Ph. Eur. leaf with a minimum essential-oil content.

The written Mediterranean trail is old and overlapping: a seaside shrub used as food, fumigant, wreath, and bitter digestive. Greek and Roman authors treated rosemary as a plant of memory and of the dead—sprigs in graves, scent in rooms, a student folklore that wearing the herb helped one remember. How much of that is S. rosmarinus in the modern sense versus a cluster of aromatic Lamiaceae is a historian’s problem; the cultural payload is not. The plant traveled with monks, markets, and later with colonial gardens far beyond the limestone it prefers.

The English-language image that still sells tinctures is Shakespeare’s. In Hamlet, Act 4, scene 5, Ophelia—distracted, handing out herbs with moral labels—says, “There’s rosemary, that’s for remembrance. Pray you, love, remember.” That is a stage emblem, not a protocol. It tells you early modern England already coded the plant as memory and fidelity. It does not tell you an essential-oil diffuser treats dementia.

Medieval and Renaissance Europe distilled “Hungary water” (eau de la reine de Hongrie) from rosemary in spirit—an early alcoholic perfume and household tonic whose recipes wander. Herbals kept the leaf for the stomach, the bath, and the hair. Culinary use never needed a monograph: lamb, beans, bread, and later roast potatoes made the pine-camphor taste ordinary. Charlemagne’s agricultural instructions and monastic garden lists helped keep it in northern plots that freeze harder than a Dalmatian hillside.

Nineteenth- and twentieth-century pharmacy separated the oil from the leaf. Camphor and cineole made the distillate a liniment and a bath scent—and, in overdose, a convulsant story. Food science later isolated why the leaf resists rancidity: carnosic acid and carnosol scavenge the chemistry of fat oxidation. In 2008 EFSA assessed rosemary extracts as antioxidants; the EU now lists them as E 392. That is a manufacturing use, not a “take this capsule for longevity” result.

The name change is recent history with a long fuse. Linnaeus published Rosmarinus officinalis in 1753. Spenner’s Salvia rosmarinus (1835) sat unused until molecular work made a broad Salvia the less-bad map. Pharmacopeias and EMA documents still title the herbal substance Rosmarinus officinalis L. because that is how the European tradition filed it. Readers should treat the two binomials as one species unless a label is doing something sloppy.

Rosemary is a mixed aromatic, not a single-molecule drug. The volatile fraction—cineole, camphor, pinene, camphene, borneol, verbenone depending on chemotype—explains the scent, the traditional “warming” bath, and the neurologic risk of the oil. Camphor is a known convulsant at sufficient dose; cineole is the same oxide famous in eucalyptus. Inhaled aroma is a small exposure. A teaspoon of undiluted oil is not.

Non-volatile phenolics do different work. Carnosic acid and carnosol are abietane diterpenes concentrated in the leaf; they are the backbone of rosemary’s food-antioxidant extracts. Rosmarinic acid is a caffeic ester shared with sage, lemon balm, and other mints—often cited in antioxidant and astringent talk. A roast sprig delivers some of both worlds. A steam-distilled oil is mostly the volatiles and is a poor source of carnosic acid. That is why “rosemary oil for antioxidants” is usually a category error.

Traditional digestive use maps onto bitter-aromatic carminative folklore: scent, saliva, and a strong flavor that people historically reached for after heavy meals. Mechanisms are not a single receptor story. Traditional cutaneous and bath use for “circulation” and sore muscle is likewise tradition-plus-counterirritant scent, not a proven vasodilator protocol for claudication.

Cognition studies that exist are mostly aroma or small extract trials in healthy adults: modest shifts on lab memory tasks, mixed speed-accuracy tradeoffs, not Alzheimer’s disease outcomes. Hair folklore now cites a 2015 randomized comparison of rosemary oil versus 2% minoxidil in androgenetic alopecia. That trial is real, limited, and not FDA approval of a hair drug.

Today the dominant honest use is culinary. Fresh sprigs or crumbled dried leaf season lamb, pork, chicken, beans, focaccia, and roasted roots. Fat carries the aroma; late addition keeps it from turning medicinal. That is food. The dose is a few needles, not a cup of oil.

European traditional herbal indications split by preparation. Dried leaf as tea (and related oral forms) is framed for symptomatic relief of dyspepsia and mild spasmodic gut complaints. The same leaf as a bath additive, and the essential oil in semi-solid cutaneous preparations, are framed for minor muscular or joint aches and for minor peripheral circulatory complaints (the heavy-legs folklore). EMA HMPC listings are traditional-use, not well-established-use: long practice, plausible, thin modern trials. Night sweats from infection, inflammatory arthritis with fever, or a cold white painful foot are diagnostic problems.

Memory and “brain fog” marketing outruns the data. Moss and colleagues (2003) found rosemary aroma associated with better scores on some memory factors in healthy adults versus a no-odor control, with a cost to speed, while lavender went the other way on several tasks. That is a lab scent study, not a treatment for dementia, ADHD, or exam season. Do not delay a memory clinic for a diffuser.

Hair growth is the current commercial wave. Panahi and colleagues (2015) randomized adults with androgenetic alopecia to rosemary oil or 2% minoxidil for six months and reported similar hair-count gains at six months, with more scalp itch in the minoxidil arm. It is one comparative trial, not a head-to-head against 5% minoxidil, oral therapies, or a dermatologist’s full workup. Rosemary oil on the scalp can irritate. It is not a substitute for indicated medical treatment when that is the right treatment.

Food preservation is the quiet industrial success. Rosemary extracts standardized to carnosic acid/carnosol are used to slow oxidation in oils, meats, and packaged foods (E 392 in the EU). Eating those foods is not the same as taking a “detox” capsule of the same extract, and the extract is not the essential oil.

Aromatherapy and liniments remain popular. Inhaled culinary-level scent is not the same as ingesting oil or using it on broken skin. Do not put rosemary oil in the eyes, on mucosa, or in a child’s bath as a folk experiment.

Kitchen use is fresh sprigs (stripped or whole in a roast) or dried leaf, which is stronger and more camphoraceous. Crushing releases oil glands. A little goes a long way.

Traditional medicinal tea is comminuted dried leaf in hot water, in labeled amounts, for short courses. EMA-style posology is time-limited: seek care if dyspepsia lasts more than about two weeks on the product, or if bath use for aches is not helping by about four weeks. Follow the pack, not a social-media handful.

Bath additives using leaf or specified oil dilutions are a separate route from tea. Do not use on broken or irritated skin. Oil in semi-solid cutaneous bases (6–10% in the EU traditional listing for the oil monograph) is a liniment-style use, not a salad dressing.

Hair recipes online often mix undiluted essential oil with a carrier. If someone tries a dilute topical, patch-test and keep it out of eyes. The 2015 trial is not a recipe blog.

Do not ingest rosemary essential oil. Distillation concentrates camphor and cineole. Capsules of leaf or antioxidant extract are still supplements with variable quality—not a reason to skip a clinician if you have gallbladder disease, liver disease, or a seizure history.

Culinary amounts are well tolerated for most people. Large bitter infusions can upset the stomach. Contact dermatitis to Lamiaceae and to the oil happens. Dried herb dust can bother sensitive noses. Baths can irritate skin.

Essential oil and high-camphor preparations can cause redness, burning, and—if swallowed or used in reckless quantity—vomiting, agitation, and seizures. That is a documented pattern for camphoraceous oils, not a tea anecdote. Children are the usual tragedy in oil poisoning stories; keep bottles capped and uninteresting.

EMA consumer language flags hypersensitivity (including contact dermatitis and, for the oil, breathing difficulty in susceptible people). Frequency is often “not known” because reporting is incomplete.

Hair-oil use can itch. That does not prove it is “working.” Minoxidil itch in the 2015 trial was more common, not absent on the rosemary side.

Do not ingest the essential oil. EMA traditional listings contraindicate rosemary leaf medicines in children under 12, and rosemary oil medicines in anyone under 18; both leaf and oil traditional products are listed as not for pregnancy or breastfeeding. Culinary seasoning in food is a different exposure. Concentrated teas, extracts, baths-as-medicine, and oils are the objects of those cautions.

Skip medicinal-dose rosemary if you have bile-duct obstruction, gallbladder inflammation, gallstones, or liver disease (leaf monograph). Skip the oil if you have known heart or kidney disease as listed in the EU oil summary, and do not apply it around the eyes or mucous membranes.

Seizure disorders and a history of camphor or essential-oil toxicity are reasons to avoid the oil and perhaps high-dose extracts unless a clinician agrees. Allergy to rosemary or other mints is a stop.

Do not use bath or cutaneous rosemary on broken skin, ulcers, or a suddenly swollen, hot, painful leg—that is a medical evaluation, not a circulatory herb.

EMA assessment at the time of the herbal monographs did not describe well-documented drug–drug interactions for traditional leaf and oil uses. That is not the same as “no interactions exist.” Concentrated extracts plus anticoagulants, anticonvulsants, or diabetes medicines belong in the “tell the pharmacist” bucket because evidence is incomplete and camphor is neurologically active in principle.

Do not stack camphoraceous oils (rosemary, some sages, eucalyptus, wintergreen-adjacent liniments) for a stronger “circulation ritual.” That is how people meet the convulsant literature.

If a clinician has prescribed minoxidil, finasteride, or another hair-loss regimen, adding rosemary oil is an experiment, not a proven upgrade. Mention it so scalp irritation is not blamed on the wrong product.

Rosemary is not St. John’s wort. Dramatic CYP induction is not its reputation. Disclosure still beats stacking “antioxidant” capsules on a narrow-therapeutic-index drug without asking.